Luying Pan possesses extensive experience in clinical biomarker innovation and development, currently serving as Senior Director at Takeda. Prior experience includes various leadership roles at Shire Pharmaceuticals, where Luying Pan advanced from Senior Scientist in Bioanalytics to the position of Director of Bioanalytical and Biomarker Development. Luying Pan holds a Doctor of Philosophy (PhD) in Physiology and Immunology from Dartmouth Medical School and a Medical Doctor Degree in Pediatrics from Shanghai Second Medical University.